SCHEMBL22609262

SCHEMBL22609262

O=C(O)c1nnsc1Nc1ccc(Br)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ILK Q13418 3/20 0.57
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
KDM1A O60341 1/20 0.38
AKR1C3 P42330 2/20 0.38
AKR1C2 P52895 2/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
CSNK2A1 P68400 1/20 0.36
PKM P14618 1/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5146289 0.86 ILK (0.73) ILKALDH1A1MAPTHTTMEN1
SCHEMBL5146269 0.85 ILK (0.77) ILKALDH1A1MAPTHTTCYP1A2
SCHEMBL22609331 0.84 ILK (0.57) ILKALDH1A1MAPTHTTCYP1A2
SCHEMBL22609326 0.82 ILK (0.56) ILKALDH1A1MAPTHTTCYP1A2
SCHEMBL23453715 0.74 ILK (0.50) ILKALDH1A1MAPTHTT
SCHEMBL5147602 0.73 ILK (1.00) ILKALDH1A1MAPTHTTHSD17B10
SCHEMBL5149415 0.71 ILK (0.73) ILKALDH1A1MAPTHTTCYP1A2
SCHEMBL5147724 0.71 ILK (0.68) ILKALDH1A1MAPTHTTHSD17B10
SCHEMBL5146319 0.71 ILK (0.73) ILKALDH1A1MAPTHTTHSD17B10
SCHEMBL22609217 0.70 KDM1A (0.43) MAPTMEN1KMT2AKDM1AAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 US disclosed
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 US disclosed
EP-3731840-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF Orfan Biotech Inc. (US) 2020-11-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF PNPO, XDH, GLS ILK 3208/4885ALDH1A1 149/4885MAPT 2376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.